【药时代智库】张琤博士

TiPLab IP Strategy联合创始人、生物医药领域执行合伙人

TiPLab IP Strategy联合创始人、生物医药领域执行合伙人

【药时代智库】张琤博士

张琤博士简介

Prior to founding TiPLab, Dr. Zhang worked as an IP specialist at Wilson Sonsini Goodrich & Rosati (WSGR). Before that, she was a patent attorney and the biotech group leader of CCPIT. Dr. Zhang has extensive experience practicing before the Chinese Intellectual Property Office, the Patent Reexamination Board, and the Chinese courts, including the Supreme Court. Dr. Zhang has helped clients from both biotech and pharmaceutical industries discover, patent, and effectively protect their innovations, which often involve a combination of various technologies, such as molecular biology, stem cell, immunology, protein engineering, molecular diagnostics, and adapted therapy, etc.

Dr. Zhang has a B.S. degree in Biological Sciences from Tsinghua University. She then obtained her Ph.D. in Molecular Biology from University of Zurich. Dr. Zhang also holds a M.Sc. degree in Intellectual Property from ETH Zurich.

 

在成立TiPLab之前,张琤博士作为知识产权专家就职于Wilson Sonsini Goodrich &Rosati (WSGR)律所,以及曾在CCPIT作为专利律师以及生物科技小组组长。张琤博士熟悉国家知识产权局、专利复审委员会以及中国法院(包括最高人民法院)的相关实践。张琤博士协助客户解决在生物技术和制药行业的专利保护中遇到的问题,并帮助客户有效地保护其创新成果,涉及的领域包括多种技术,如分子生物学、干细胞免疫学、蛋白质工程、分子诊断、个性化医疗等。

张琤博士毕业于清华大学,并在瑞士苏黎世大学获得分子生物学博士学位,在瑞士苏黎世联邦理工学院获得知识产权硕士学位。

发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权

发表评论

登录后才能评论
分享本页
返回顶部